390 related articles for article (PubMed ID: 18606742)
1. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
2. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.
Yabuuchi H; Tamai I; Nezu J; Sakamoto K; Oku A; Shimane M; Sai Y; Tsuji A
J Pharmacol Exp Ther; 1999 May; 289(2):768-73. PubMed ID: 10215651
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier transport of pramipexole, a dopamine D2 agonist.
Okura T; Ito R; Ishiguro N; Tamai I; Deguchi Y
Life Sci; 2007 Apr; 80(17):1564-71. PubMed ID: 17307202
[TBL] [Abstract][Full Text] [Related]
4. Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in mice.
Kato S; Kato Y; Nakamura T; Sugiura T; Kubo Y; Deguchi Y; Tsuji A
Biopharm Drug Dispos; 2009 Dec; 30(9):495-507. PubMed ID: 19821448
[TBL] [Abstract][Full Text] [Related]
5. Involvement of an influx transporter in the blood-brain barrier transport of naloxone.
Suzuki T; Ohmuro A; Miyata M; Furuishi T; Hidaka S; Kugawa F; Fukami T; Tomono K
Biopharm Drug Dispos; 2010 May; 31(4):243-52. PubMed ID: 20437463
[TBL] [Abstract][Full Text] [Related]
6. Blood-to-brain influx transport of nicotine at the rat blood-brain barrier: involvement of a pyrilamine-sensitive organic cation transport process.
Tega Y; Akanuma S; Kubo Y; Terasaki T; Hosoya K
Neurochem Int; 2013 Jan; 62(2):173-81. PubMed ID: 23228345
[TBL] [Abstract][Full Text] [Related]
7. Saturable distribution of tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport.
Sung JH; Yu KH; Park JS; Tsuruo T; Kim DD; Shim CK; Chung SJ
Drug Metab Dispos; 2005 Mar; 33(3):440-8. PubMed ID: 15547049
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
9. Transport characteristics of tramadol in the blood-brain barrier.
Kitamura A; Higuchi K; Okura T; Deguchi Y
J Pharm Sci; 2014 Oct; 103(10):3335-41. PubMed ID: 25175482
[TBL] [Abstract][Full Text] [Related]
10. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
11. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells.
Kobayashi D; Irokawa M; Maeda T; Tsuji A; Tamai I
Reproduction; 2005 Dec; 130(6):931-7. PubMed ID: 16322553
[TBL] [Abstract][Full Text] [Related]
12. Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
Suzuki T; Aoyama T; Suzuki N; Kobayashi M; Fukami T; Matsumoto Y; Tomono K
Biopharm Drug Dispos; 2016 Sep; 37(6):323-35. PubMed ID: 27146715
[TBL] [Abstract][Full Text] [Related]
13. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
[TBL] [Abstract][Full Text] [Related]
14. Choline transport via choline transporter-like protein 1 in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBT.
Lee NY; Choi HM; Kang YS
Placenta; 2009 Apr; 30(4):368-74. PubMed ID: 19246089
[TBL] [Abstract][Full Text] [Related]
15. mRna expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting.
Hosoya KI; Takashima T; Tetsuka K; Nagura T; Ohtsuki S; Takanaga H; Ueda M; Yanai N; Obinata M; Terasaki T
J Drug Target; 2000; 8(6):357-70. PubMed ID: 11328662
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells.
Han YH; Sweet DH; Hu DN; Pritchard JB
J Pharmacol Exp Ther; 2001 Feb; 296(2):450-7. PubMed ID: 11160630
[TBL] [Abstract][Full Text] [Related]
17. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier.
Miecz D; Januszewicz E; Czeredys M; Hinton BT; Berezowski V; Cecchelli R; Nałecz KA
J Neurochem; 2008 Jan; 104(1):113-23. PubMed ID: 17995936
[TBL] [Abstract][Full Text] [Related]
18. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Ohashi R; Tamai I; Yabuuchi H; Nezu JI; Oku A; Sai Y; Shimane M; Tsuji A
J Pharmacol Exp Ther; 1999 Nov; 291(2):778-84. PubMed ID: 10525100
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of carrier-mediated uptake of epirubicin reduces cytotoxicity in primary culture of rat hepatocytes.
Iwakiri T; Okumura M; Hidaka M; Kumagai Y; Ichihara E; Kawano Y; Arimori K
J Appl Toxicol; 2008 Apr; 28(3):329-36. PubMed ID: 17604344
[TBL] [Abstract][Full Text] [Related]
20. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
